UAE-Funded XCath Achieves World's First Telerobotic Stroke Surgery
UAE-funded robotics startup XCath successfully completed the world's first-in-human telerobotic stroke procedure. This milestone follows a recent $30 million Series C funding round co-led by Crescent Enterprises.
XCath, a robotics startup backed by UAE funding, has achieved a significant medical breakthrough by performing the world's first-in-human telerobotic stroke surgery. This procedure demonstrates a major advancement in applying robotics to complex medical interventions.
The achievement highlights the impact of recent investment in the company, which secured $30 million in a Series C funding round. Crescent Enterprises co-led this funding, underscoring local support for innovative deep-tech ventures.
The successful surgery positions XCath at the forefront of telerobotic medicine, potentially transforming stroke treatment and patient outcomes. It also showcases the UAE's growing role in fostering cutting-edge technological development.